Los Angeles Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,593
| Closed | -$187K | – | 1246 |
|
|
2024
Q1 | $187K | Buy |
+21,593
| New | +$187K | ﹤0.01% | 1110 |
|
|
2023
Q4 | – | Sell |
-10,187
| Closed | -$102K | – | 1200 |
|
|
2023
Q3 | $102K | Sell |
10,187
-2,032
| -17% | -$20.3K | ﹤0.01% | 1091 |
|
|
2023
Q2 | $152K | Hold |
12,219
| – | – | ﹤0.01% | 1128 |
|
|
2023
Q1 | $171K | Hold |
12,219
| – | – | ﹤0.01% | 1131 |
|
|
2022
Q4 | $175K | Buy |
+12,219
| New | +$175K | ﹤0.01% | 1148 |
|
|
2022
Q3 | – | Sell |
-81,092
| Closed | -$2.3M | – | 1327 |
|
|
2022
Q2 | $2.3M | Sell |
81,092
-33,103
| -29% | -$941K | 0.01% | 504 |
|
|
2022
Q1 | $4.03M | Buy |
114,195
+66,134
| +138% | +$2.33M | 0.02% | 395 |
|
|
2021
Q4 | $2.01M | Buy |
48,061
+11,974
| +33% | +$502K | 0.01% | 512 |
|
|
2021
Q3 | $1.77M | Sell |
36,087
-417,506
| -92% | -$20.5M | 0.01% | 558 |
|
|
2021
Q2 | $18.9M | Buy |
+453,593
| New | +$18.9M | 0.08% | 208 |
|